Counteracting Effects of Cellular Notch and Epstein-Barr Virus EBNA2: Implications for Stromal Effects on Virus-Host Interactions

The pathogenesis of Epstein–Barr virus persistent infection

(2013) David A Thorley-Lawson et al.   Current Opinion in Virology

Genome-Wide Analyses of Zta Binding to the Epstein-Barr Virus Genome Reveals Interactions in both Early and Late Lytic Cycles and an Epigenetic Switch Leading to an Altered Binding Profile

(2012) S. Ramasubramanyan et al.   JOURNAL OF VIROLOGY

Soluble factors produced by activated CD4+ T cells modulate EBV latency

(2012) N. Nagy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The B-Cell Specific Transcription Factor, Oct-2, Promotes Epstein-Barr Virus Latency by Inhibiting the Viral Immediate-Early Protein, BZLF1

(2012) Amanda R. Robinson et al.   PLoS Pathogens

Cellular Transcription Factor Oct-1 Interacts with the Epstein-Barr Virus BRLF1 Protein To Promote Disruption of Viral Latency

(2011) A. R. Robinson et al.   JOURNAL OF VIROLOGY

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma

(2010) L. L. Kis et al.   BLOOD

Cellular MicroRNAs 200b and 429 Regulate the Epstein-Barr Virus Switch between Latency and Lytic Replication

(2010) A. L. Ellis-Connell et al.   JOURNAL OF VIROLOGY

Either ZEB1 or ZEB2/SIP1 Can Play a Central Role in Regulating the Epstein-Barr Virus Latent-Lytic Switch in a Cell-Type-Specific Manner

(2010) A. L. Ellis et al.   JOURNAL OF VIROLOGY

Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells

(2009) H. Kohlhof et al.   BLOOD

The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism

(2009) Raphael Kopan et al.   CELL

Wide-Scale Use of Notch Signaling Factor CSL/RBP-J  in RTA-Mediated Activation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Genes

(2009) L. M. Persson et al.   JOURNAL OF VIROLOGY

Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome Amplification

(2009) C. Shannon-Lowe et al.   JOURNAL OF VIROLOGY

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter

(2009) L. L. Kis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo

(2008) L. J. Anderson et al.   BLOOD

An auto-regulatory loop for EBV LMP2A involves activation of Notch

(2007) Leah J. Anderson et al.   VIROLOGY